Back to top

Veradermics initiated with a Buy at B. Riley

B. Riley initiated coverage of Veradermics (MANE) with a Buy rating and $170 price target The firm views the company’s lead asset VDPHL01, an exten...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: